Theoretical Risks with Chronic Use Some concerns raised by clinicians and researchers include: Unregulated angiogenesis: Overstimulation of blood vessel growth could hypothetically support tumor progression in cancer-prone individuals Unknown hormonal crosstalk: While BPC-157 is non-hormonal, it interacts with systems (e.g., nitric oxide, dopamine) that may influence downstream signaling Immune tolerance or desensitization: Chronic exposure to any peptide could alter immune recognition or receptor sensitivity over time These concerns are theoretical , but they highlight why BPC-157 should not be used indefinitely or in uncontrolled cycles
Inject on the outer side of the thigh, approximately one hand's width above the knee or one hand's width below the hip
Delayed Treatment: Vitamin B12 deficiency left untreated for longer than 3 months may cause permanent spinal cord and nerve damage
The jury is still out as to whether B12 shots are helpful or harmful for babies in the womb
Most of what we know about BPC-157 comes from preclinical research (mainly animal studies) and anecdotal user experiences
79 There was also a clear conflict of interest, as the physicians running the study were affiliated with the clinic providing (and profiting from) the peptide therapy
